Phase II Study of L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma
The prognosis of patients with progressive and recurrent NK/T cell lymphoma is poor
partially due to lack of effective treatment. L-asparaginase was reported to be effective in
this setting by several case reports. The investigators aim to evaluate the efficacy and
toxicity of L-asparaginase monotherapy in a prospective phase II study.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Ye Guo, MD
China: Ethics Committee